Thursday 31 January 2019

Detailed Information On Gastrointestinal Diseases Drug Development Pipeline Review, 2018

Researchmoz added Most up-to-date research on "Detailed Information On Gastrointestinal Diseases Drug Development Pipeline Review, 2018" to its huge collection of research reports.

Gastrointestinal Diseases Drug Development

This report provides an overview of the pipeline landscape for gastrointestinal diseases. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for gastroenteritis, enterocolitis, gastritis and peritonitis, and features dormant and discontinued products.

Gastroenteritis is an infection of the gut. Symptoms include stomach pain, cramping, fever, nausea, and a headache. Causes of gastroenteritis include contaminated food or water and contact with someone who has the virus. Treatment includes antibiotics, anti-emetic and anti-diarrheal medications. There are 12 products in development for this indication.

Enterocolitis is an inflammation of the large and small intestines. Symptoms include fever, abdominal swelling, nausea, diarrhea, rectal bleeding and sluggishness. Causes of enterocolitis include inflammation of the intestinal tissues, delayed gastric emptying, abdominal wall erythema, apnea, sepsis and cardiovascular collapse. Treatment includes antibiotics. There are eight products in development for this indication.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=2028310

Gastritis is characterized by inflammation or swelling of the lining of the stomach. Acute gastritis lasts for a short period of time while chronic gastritis lasts for a long period of time (months to years). Gastritis can be caused by medications such as ibuprofen, aspirin, naproxen on long periods of consumption, excess intake of alcohol, Helicobacter pylori infection, certain autoimmune disorders, bile reflux, substance abuse (cocaine), consumption of corrosive or caustic substances such as poisons, extreme stress, viral infections and trauma. The symptoms of gastritis may include loss of appetite, nausea and vomiting, abdominal pain and black stools. Treatment includes use of antacids, histamine 2 (H2) antagonists and proton pump inhibitors. There are 11 products in development for this indication.

Peritonitis is inflammation of the peritoneum. There are two types of peritonitis. Spontaneous bacterial peritonitis is the result of an infection of the fluid in the peritoneal cavity. Secondary peritonitis is usually due to an infection that has spread from the digestive tract. Symptoms include abdominal bloating, nausea and vomiting, diarrhea, fatigue, fever and chills. Treatment includes antibiotics. There are seven products in development for this indication.

Browse TOC @ https://www.researchmoz.us/gastrointestinal-diseases-drug-development-pipeline-review-2018-report.html/toc

Molecular targets in development for gastrointestinal diseases include toll-like receptors, interleukin receptors and bacterial proteins. Companies operating in this pipeline space include Kyowa Hakko Kirin, RedHill Biopharma and GlaxoSmithKline.

Scope
- Which companies are the most active within each pipeline?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in this disease area?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Global Womens Health Drugs Market to 2024 - Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth

Researchmoz added Most up-to-date research on "Global Womens Health Drugs Market to 2024 - Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth" to its huge collection of research reports.

The womens health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The womens health market is relatively small considering the high prevalence of many womens health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within womens health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=2047690

Scope
- There are 277 pipeline products in active development for womens health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within womens health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the womens health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the womens health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to womens health products have been completed since 2006. Which types of assets attracted the largest deal values?

Browse TOC @ https://www.researchmoz.us/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth-report.html/toc

Reasons to buy
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drugs mechanism of action.
- Analyze the womens health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the womens health deals landscape by analyzing trends in licensing and co-development deals.

India Animal Health Care Market Is Expected To Register A CAGR Of 8.0% During The Forecast Period 2016 – 2024

Researchmoz added Most up-to-date research on "India Animal Health Care Market Is Expected To Register A CAGR Of 8.0% During The Forecast Period 2016 – 2024" to its huge collection of research reports.

In terms of revenue, the India animal health care market is expected to register a CAGR of 8.0% during the forecast period, 2016–2024. The primary objective of the report is to offer insights on the market dynamics that can influence growth of the India animal health care market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies operating in the India animal health care market are presented in the report.
The India animal health care market is expected to witness significant growth rate in terms of value owing to Increase in consumption of animal protein among human population, rise in epidemics of animal diseases, significant animal population and better technology and growing awareness about animal health management practices contributes to growth of the animal health care market. Moreover, development of novel drugs and vaccines against various animal diseases is creating high potential growth opportunities for players operating in the India animal health care market.


Revenue from the animal health care market in India is expected to expand at the relatively higher CAGR due to rising awareness for veterinary care and development of strong distribution channel in India. To understand and assess opportunities in this market, the report offers market forecast on the basis of animal type, therapeutic applications and zones. The report provides analysis of the India animal health care market in terms of market value (US$ Mn).
India Animal Health Care Market: Segmentation
The India animal health care market is segmented on the basis of animal type: Livestock and Companion. The report begins with the market definition, followed by definitions of the different animal types and different therapeutic applications. The market dynamics section includes TMR’s analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the India animal health care market. Next, the report analyses the market on the basis of regions and presents forecast in terms of value for the next 10 years. On the basis of zone, the India animal health care market is segmented into North India, East India, West India, and South India.


We have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the India animal health care market. Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked, while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by animal health care market. To understand key segments in terms of their growth and performance in the India animal health care market, Transparency market research has developed a market attractiveness index. The resulting index would help providers identify existing market opportunities.
India Animal Health Care Market: Competitive Analysis
In the final section of the report, a ‘competitive landscape’ has been included to provide a dashboard view of key companies operating in the India animal health care market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the India animal health care market and the potential players. However, this section also includes market strategies and SWOT analysis of the main players operational in the India animal health care market.
Detailed profiles of players operating in India animal health care market are also included in the scope of the report to evaluate their long- and short-term strategies. Key players included in this report are Merck & Co., Inc. (Intervet India Pvt. Ltd.), Zoetis, Inc., Bayer AG, Elanco, Merial, Boehringer Ingelheim GmbH, Virbac Group, Ceva Santé Animale, Vetoquinol, Intas Pharmaceuticals Ltd., Cipla, Inc. (Cipla Vet), Cargill, Incorporated, Venkys India, Zydus Animal Health, The Himalaya Drug Company, Ayurvet Limited, and Natural Remedies Pvt. Ltd., among others.
The India animal health care market has been segmented as follows:
By Zone
  • North India
  • East India
  • West India
  • South India
By Animal Type
  • Livestock
  • Bovine Species
  • Porcine Species
  • Ovine Species
  • Poultry Species
  • Companion
  • Canine Species
  • Feline Species
By Distribution Channel
  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug Stores
  • Others (Direct Distribution, Pet Shops)
By Therapeutic Type
  • Drugs
  • Anti-infective by route of administration
  • Analgesic, Antipyretic, and Anti-inflammatory by route of administration
  • Parasiticides by route of administration
  • Dewormers by route of administration
  • Others by route of administration
  • Vaccines
  • Live Attenuated Vaccine by route of administration
  • Inactivated Vaccine by route of administration
  • Other Vaccine by route of administration

Global Fresh Meat Packaging Market Likely To Reach US$2.47 Bn By 2026 - Industry Analysis, Trends and Forecast

Researchmoz added Most up-to-date research on "Global Fresh Meat Packaging Market Likely To Reach US$2.47 Bn By 2026 - Industry Analysis, Trends and Forecast" to its huge collection of research reports.

This report provides forecast and analysis of the fresh meat packaging market on Global level. It provides historical data of 2015 along with estimated data of 2016, and forecast data up to 2026 in terms of revenue (US$ Mn) and volume (‘000 Tonnes). The report also includes macroeconomic indicators along with an outlook on fresh meat consumption pattern across the globe. It includes drivers and restraints of the global fresh meat packaging market and their impact on each region during the forecast period. The report also comprises the study of current issues with end users and opportunities for fresh meat manufacturers. It also includes value chain analysis.
In order to provide users of this report with comprehensive view of the market, we have included detailed competitiveness analysis and company players with their SWOT analysis and strategy overview. The dashboard provides detailed comparison of fresh meat manufacturers on parameters such as operating margin, total revenue, product portfolio, and what we call ‘innovation scale’. The study encompasses market attractiveness analysis by packaging technology, material, meat type and region.


Global Fresh Meat Packaging Market: Segmentation
The report includes consumption of fresh meat and the revenue generated from sales of fresh meat across the globe and important countries. By material type the market has been segmented into polyethylene (PE), polypropylene (PP), biaxially oriented polypropylene film (BOPP), Ethylene vinyl alcohol (EVOH), polyvinyl chloride (PVC), polyamide (PA) and others. The global fresh meat packaging market has been segmented on the basis of meat type such as beef, pork, poultry, seafood, and others. On the basis of packaging technology type, the market has been segmented into Modified Atmosphere Packaging (MAP), Vacuum Skin Packaging (VSP), Vacuum Thermoformed Packaging (VTP) and others.
Market numbers have been estimated based on data available from Food and Agricultural Organization (FAO) website, and extensive secondary and primary research, average pricing of fresh meat by material type and the revenue is derived through regional pricing trends. Market size and forecast for each segment have been provided in the context of global and regional markets. The fresh meat packaging market has been analyzed based on expected demand. Prices considered for the calculation of revenue are average regional prices obtained through primary quotes from numerous regional fresh meat manufacturers, suppliers, and distributors. All key end users have been considered and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents.


Country demand patterns have been considered while estimating the market for various end users of fresh meat in the different regions. Top-down approach has been used to estimate the fresh meat packaging market by regions. Global market numbers by packaging technology type, material type and meat type have been derived using the bottom-up approach, which is cumulative of each country’s demand. Company-level market share has been derived on the basis of revenues reported by key manufacturers. The market has been forecast based on constant currency rates. A number of primary and secondary sources were consulted during the course of the study. Secondary sources include Factiva, FAO, Packaging Digest, and Hoover’s, and company annual reports and publications.
Companies Mentioned in the Report
The report provides detailed competitive and company profiles of key participants operating in the Global market. Key players in Global fresh meat packaging include Coveris Holdings SA, KOROZO Ambalaj San.ve Tic A.S., Bollore Group, Mondi Group, Winpak Ltd., Berry Plastics Corporation, Bemis Company, Inc., E.I. du Pont de Nemours & Co, Sealed Air Corporation, and Amcor Limited
The global fresh meat packaging market has been segmented as below:
By Packaging Technology Type
  • Modified Atmosphere Packaging (MAP)
  • Vacuum Skin Packaging (VSP)
  • Vacuum Thermoformed Packaging (VTP)
  • Others
Material Type
  • PE
  • PP
  • BOPP
  • EVOH
  • PVC
  • PA
  • Others
Meat Type
  • Beef
  • Pork
  • Poultry
  • Seafood
  • Others
By Region
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Middle East & Africa (MEA)
  • Japan

Global Ileostomy Market Anticipated To Reach US$1.65 Bn By 2024, Expanding At A CAGR Of 8.9% From 2016 To 2024

Researchmoz added Most up-to-date research on "Global Ileostomy Market Anticipated To Reach US$1.65 Bn By 2024, Expanding At A CAGR Of 8.9% From 2016 To 2024" to its huge collection of research reports.

Global Ileostomy Market

Creating stoma which is an opening in human body to remove waste produced inside the body is defined as ostomy. Ostomy is the surgery procedure used for treating diseases like cancer, inflammatory bowel disease (IBD) etc. Ostomy in different parts of the body are named accordingly such as ileostomy for small intestine, colostomy for colon, and urostomy for bladder. 

This report studies the current scenario as well as future market potential for Ileostomy globally. This report provides an elaborate executive summary, which includes the market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner.
This report provides in-depth analysis of the ileostomy market. The stakeholders for this report include companies involved in the manufacturing of ileostomy, companies providing raw material for manufacturing ileostomy, and companies providing equipment for manufacturing. For providing the snapshot of the market to stakeholders, an executive summary section has been included in the report, which mainly summarizes the market trends, competition and size of different regions.


Global Ileostomy Market: Scope of the Report
The market overview section of this report analyzes market dynamics such as drivers, restraints and opportunities that influence the ileostomy market in the current and future scenario. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the ileostomy market. All these factors will help the market players to decide about the business strategies and plans to be incurred in future for strengthening their position in the global market.
The report provides market estimation of ileostomy market in terms of revenue (US$ Mn) for all the segments and sub segments with CAGR % for the period from 2016 to 2024, considering 2015 as the base year. The report also provides the volume of ileostomy procedures for the segment by type of procedures and by geography with CAGR % for the period from 2016 to 2024. Furthermore, the report incorporates market attractiveness analysis by geography category that depicts the most attractive region in the global market during the forecast period from 2016 to 2024.


Global Ileostomy Market: Key Segments
The ileostomy market has been segmented based on procedure type, equipment type, disease condition and end user. Based on procedure type, the global ileostomy market has been segmented into end ileostomy and loop ileostomy. Based on equipment type, the global ileostomy market has been segmented into stoma bags, support belts & girdles, adhesive remover sprays, and protective stoma guards. Based on disease condition type, the global ileostomy market has been segmented into cancer, diverticulitis, ulcerative colitis, Crohn’s disease and others. Based on end users type, the global ileostomy market has been segmented into hospitals, ambulatory surgical centers, and research centers.
Geographically, the Ileostomy market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Italy, and Spain have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the Ileostomy market in various regions has been provided in this section.
Companies Mentioned in the Report
This report also includes key market trends and major opportunities that will assist new companies in establishing their presence and market players in expanding their market share in the ileostomy market. The report concludes with the company profile section which includes company overview, financial overview, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Smith & Nephew, Convatec Inc., 3M Healthcare, B. Braun Melsungen AG, Coloplast, Hollister Incorporated, Salts Healthcare, Flexicare Medical Ltd., Marlen Manufacturing, and Pelican Healthcare.
The global Ileostomy market has been segmented into:
Global Ileostomy Market, by Procedure Type
  • End Ileostomy
  • Loop Ileostomy
Global Ileostomy Market, by Equipment
  • Stoma Bags
  • Belt & Girdles
  • Adhesive Sprays
  • Stoma Guards
Global Ileostomy Market, by Disease Condition
  • Cancer
  • Diverticulitis
  • Ulcerative Colitis
  • Crohn’s Disease
  • Others
Global Ileostomy Market, by End User
  • Hospitals
  • Ambulatory Centers
  • Research Centers
Global Ileostomy Market, by Geography
  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Global Bio Vanillin Market Expected To Reach US$14.34 Mn By 2025, To Exhibit A CAGR Of 7.4% Between 2017 - 2025

Researchmoz added Most up-to-date research on "Global Bio Vanillin Market Expected To Reach US$14.34 Mn By 2025, To Exhibit A CAGR Of 7.4% Between 2017 - 2025" to its huge collection of research reports.

The report covers the analysis and forecast of the bio vanillin market on a global and regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn) and Volume (Tons). 
The study provides a comprehensive view of the bio vanillin market by segmenting it based on application. By application, the bio vanillin market has been segregated into food, beverages, pharmaceuticals and fragrances. Food has been further sub-segmented into ice cream, baked goods, chocolates and others. 
Regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. These have been further sub-segmented into countries and regions with relevance to the market. The segmentation also includes demand for individual product and applications in all regions. 
The competitive profiling of the key players in the global bio vanillin market across five broad geographic regions is included in the study. These include different business strategies adopted by the leading players and their recent developments as in the field of bio vanillin. 


Global Bio Vanillin Market: Scope of the Report 
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints and opportunities is included in the purview of the report. Additionally, the report includes potential opportunities in the bio vanillin market on the global and regional level. Market dynamics are the factors which impact the market growth, thereby helping to understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the bio vanillin market. 
The report provides the size of the bio vanillin market in2016 and the forecast for the next nine years up to 2025. The size of the global bio vanillin market is provided in terms of both volume and revenue. Market revenue and volume is defined in US$ Mn and Tons respectively. The market size and forecast for each application segment are provided in the context of global and regional markets. Numbers provided in this report are derived based on demand generated from different applications. Market dynamics prevalent in North America, Europe and Asia-Pacific have been taken into account for estimating the growth of the global market. 


Global Bio Vanillin Market: Research Methodology 
Market estimates for this study have been based revenue being derived through regional pricing trends. The price for commonly utilized quality of bio vanillin in each application has been considered. Demand for bio vanillin has been derived by analyzing the global and regional demand for bio vanillin in each application for its respective functions. The global bio vanillinmarket has been analyzed based on expected demand. Average selling price of bio vanillin products in the major countries has been taken into consideration to estimate regional and global revenue. Forecasts have been based on the expected demand from bio vanillin applications. We have used the bottom-up approach to estimate the global revenue of bio vanillin market, split into regions. We have initially determined the volume and price in every region for the bio vanillin market. Revenue has been determined with the help of volume and price derived from every region. 
Based on application, we have summed up the individual revenues from all the regions to achieve the global revenue for bio vanillin. The application split of the market has been derived using a bottom-up approach for each regional market separately, with the global application segment split being an integration of regional estimates. Companies were considered for the market share analysis based on their product portfolio, revenue, and manufacturing capacity. In the absence of specific data related to the sales of bio vanillin of several privately held companies, calculated assumptions have been made in view of the company’s product portfolio and regional presence along with the demand for products in its portfolio. 
Companies Mentioned in the Report 
The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. The key players in the bio vanillin market are Solvay SA, GivaudanSA, Firmenich SA, Apple Flavor & Fragrance Group Co., Ltd., Advanced Biotech, Evolva Holding SA, Lesaffre, Archer Daniels Midland Company, Aurochemicals and Borregaard..
The market has been segmented as follows:
Global Bio Vanillin Market: By Geography
  • North America
  • U.S.
  • Rest of North America
  • Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
  • Middle East and Africa
  • Saudi Arabia
  • Rest of Middle East and Africa
  • Latin America
  • Brazil
  • Rest of Latin America
Global Bio Vanillin Market: By Application
  • Food
  • Ice-Cream
  • Baked goods
  • Chocolates
  • Others
  • Beverages
  • Pharmaceuticals
  • Fragrances

Global Ethoxyquin Market Expected To Rise At A CAGR Of 4.50% Durig 2017 - 2025, To Reach US$255.0 Mn By The End Of 2025

Researchmoz added Most up-to-date research on "Global Ethoxyquin Market Expected To Rise At A CAGR Of 4.50% Durig 2017 - 2025, To Reach US$255.0 Mn By The End Of 2025" to its huge collection of research reports.

Transparency Market Research offers an 8-year forecast for the global ethoxyquin market between 2017 and 2025. In terms of value, the market is expected to register a CAGR of 4.5% during the projected period. The primary objective of the report is to offer insights on the advancements in the ethoxyquin market. The study demonstrates market dynamics that are expected to influence the current environment and future status of the global ethoxyquin market over the forecast period. The primary objective of this report is to offer updates on trends, drivers, restraints, value forecasts, and opportunities for manufacturers operating in the global ethoxyquin market. 
The global ethoxyquin market has been witnessing significant increase owing to increasing application of ethoxyquin in animal and poultry feeds. Ethoxyquin is used to control the generation of lipid oxidation compounds and to mitigate the effects of oxidized fats in animal diets. Increasing global population and rising need for dairy, meat, and poultry products globally is driving demand for feeds for livestock. Furthermore revenue from the global ethoxyquin market has been witnessing significant increase owing to increasing application of ethoxyquin in animal and poultry feeds. 


Global Ethoxyquin Market: Scope of the Study 
A section of report discusses on how the overall competition in the market is steadily increasing. It discusses various factors that are shaping internal as well as external competition in the market. Overall internal competition in the ethoxyquin market is studied to be comparatively high due to number of major providers of ethoxyquin products in the market. The global ethoxyquin market is facing relatively low external competition from producers as similar products such as BHT and BHA are generally provided by the same manufacturers. Ethoxyquin-95 Oil, ethoxyquin-66 powder, and ethoxyquin-33 powder are the key products available in the global market for ethoxyquin. 
The report talks about the market share of total ethoxyquin market by different application segment including pesticides, pet food preservatives, poultry industry, aquaculture industry, spice color preservatives, industrial application. A section of the report highlights ethoxyquin demand, region-wise. It provides a market outlook for 2017–2025. This study discusses key trends contributing to growth of the ethoxyquin market globally, as well as analyses the degree to which drivers are influencing the market in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific (APAC) and Middle East and Africa (MEA). 


Global Ethoxyquin Market: Competitive Outlook 
In the final section of the report, a competitive landscape has been included to provide report audiences with a dashboard view. Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the ethoxyquin space. 
Key players in the global ethoxyquin market include Industrial Técnica Pecuaria, S.A. (ITPSA), Shanghai Fuda Fine Material Co., Ltd., Mitsui & Co., Ltd., Merck KGaA, Camlin Fine Sciences Ltd., Rensin Chemicals Limited, Jiangsu Zhongdan Group Co. Ltd., Impextraco N.V, Kemin Industries, Inc., Skystone Feed Co. Ltd. 
The global ethoxyquin market is segmented into: 
By Product Type
  • Ethoxyquin- 95 Oil
  • Ethoxyquin- 66 Powder
  • Ethoxyquin- 33 Powder 
By Application
  • Pesticides
  • Pet Food Preservatives
  • Poultry Industry
  • Aquaculture Industry
  • Spice Color Preservatives
  • Industrial Application 
By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • EU5
  • Nordic
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • A&NZ
  • Rest of APAC
  • Middle East & Africa
  • GCC
  • North Africa
  • South Africa
  • Rest of MEA

Global Confectionery Ingredient Market Likely To Rise At A CAGR Of 4.20% Between The Period 2017 - 2025

Researchmoz added Most up-to-date research on "Global Confectionery Ingredient Market Likely To Rise At A CAGR Of 4.20% Between The Period 2017 - 2025" to its huge collection of research reports.

Confectionery ingredients are used in the manufacturing of end products like chocolate, bakery products, beverages, sugar confectioneries among others. These ingredients include cocoa, dairy ingredients, emulsifiers, sugar, sweeteners and others in order to make a good product in the market for sale. These ingredients need to be mixed in required quantities in order to make a confectionery item. Sweeteners are a replacement of sugar products in the market and they considered as a healthy additive for health conscious consumers. They are less in calories and provide the same taste as that of sugar. Rapid consumption of chocolate is driving the growth of the chocolate market which is in turn fueling the demand for confectionery ingredients. 
Consumer awareness regarding the health benefits of consuming chocolate is fueling the demand for confectionery ingredients. Cocoa and other dairy ingredients added to chocolate are reported to have beneficial health related qualities. The cocoa content offers relief from illnesses such as high blood pressure, cholesterol, and other neurodegenerative diseases. Furthermore, the demand for confectionery products is increasing due to the changing demand of consumers and the influence of the western culture in terms of feeding habits in the developing economies. Confectionery items have become a necessary food item in recent times. The consumer’s lifestyle along with their demand changes with time and in order to meet their requirements, manufacturers of confectionery products including bakery are exploring with ingredients which is also backed by huge investments in research and development. However, confectionery manufacturers need to abide by various regulations and conditions while procuring ingredients and processing them into end products. 


The cost of good quality ingredients is high, and international food regulatory organizations keep a check on suppliers and manufacturers to deliver a gourmet confectionery product to end consumers. High sugar content, adding of artificial flavors, and color are often harmful for the end products. For example, in India, non-permitted colorants are often added in many dairy products like milk, resulting in health hazards. According to Global Food Safety Initiative (GFSI), food retailers are demanding certifications from their suppliers due to the complex challenges faced by the food supply chain. Therefore, manufacturers find it difficult to meet the cost of purchasing good quality and high cost ingredients, and simultaneously keeping a check on the certifications of the supplier’s products. 
Global Confectionery Ingredients Market: Segmentation 
The global confectionery ingredient market is segmented into five types- chocolate & cocoa, emulsifiers, sugar, sweeteners, dairy ingredients. The global confectionery ingredient market was analyzed and found that the chocolate and cocoa segment has accounted for the largest market share in 2016. Furthermore, the market is categorized into two form as dry and liquid. The dry form of confectionery ingredient is the most widely used ingredient in the manufacturing of confectionery products due to its functional and operational excellence. 


In addition, the global confectionery ingredient market is segregated into four segments- chocolate, sugar confectionery, bakery and others. The chocolate is the most widely used application in the confectionery industry. Not only because of its taste, but also the form of dark chocolate is good for health. 
Geographically, the market has been further divided into five regions which include North America, Europe, Asia Pacific, Middle East and Africa and Latin America. Europe accounted for the largest market for confectionery ingredient in 2016. North America held the second largest share with over 25% of the global confectionery ingredient market in 2016. Asia Pacific region has been identified to be the most promising and has been analyzed to have the fastest growth during the forecast period. 
Companies Mentioned in the Report 
The major players operating in the global confectionery ingredient market include Cargill Corporation, Olam International Ltd., E. I. Du Pont De Nemours and Co., Archer Daniels Midland, Barry Callebaut, Kerry Group, Tate and Lyle Plc, Koninklijke DSM N.V., ZuChem Inc., and Ingredion Inc..?
The segments covered in the global confectionery ingredients market are as follows: 
By Types
  • Chocolate & Cocoa
  • Sugar
  • Dairy Ingredients
  • Emulsifiers
  • Sweeteners
  • Others 
By Form
  • Dry
  • Liquid 
By Application
  • Chocolate
  • Sugar Confectionery
  • Bakery
  • Others 
By Geography
  • North America
  • U.S.
  • Rest of North America
  • Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
  • Middle East and Africa
  • UAE
  • South Africa
  • Rest of MEA
  • Latin America
  • Brazil
  • Rest of Latin America

Global Vaccines Delivery Devices Market Future Strategy with Top manufacturers - BD, Schott, 3M, Gerresheimer, Pharmajet and Panacea Pharmaceuticals

Researchmoz added Most up-to-date research on "Global Vaccines Delivery Devices Market Future Strategy with Top manufacturers - BD, Schott, 3M, Gerresheimer, Pharmajet and Panacea Pharmaceuticals" to its huge collection of research reports.

The global Vaccines Delivery Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vaccines Delivery Devices market based on company, product type, end user and key regions.

This report studies the global market size of Vaccines Delivery Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Vaccines Delivery Devices in these regions.

This research report categorizes the global Vaccines Delivery Devices market by top players/brands, region, type and end user. This report also studies the global Vaccines Delivery Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=2039735

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
BD
Schott
3M
Gerresheimer
Pharmajet
Panacea Pharmaceuticals
Valeritas
Vaxxas
Corium International

Market size by Product
Intranasal Delivery Devices
Intradermal Delivery Devices
Market size by End User
Hospitals
Clinics
Others

Browse TOC @ https://www.researchmoz.us/global-vaccines-delivery-devices-market-insights-forecast-to-2025-report.html/toc

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Vaccines Delivery Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Vaccines Delivery Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Vaccines Delivery Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Vaccines Delivery Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Vaccines Delivery Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Vaccines Delivery Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.